Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiwerth

Showing results (271-280 of 321) with videos related to

Pageof 33
Sort By:
International Journal of Molecular Sciences|May 27, 2026
Early Peripheral Blood <i>WT1</i> Expression Predicts Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid LeukemiaViktor Blaslov, Margareta Radic Antolic, Ivana Horvat, et al.
Pharmaceuticals (Basel, Switzerland)|April 27, 2024
The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter ActivityPredrag Sikiric, Alenka Boban Blagaic, Sanja Strbe, et al.
Burns : Journal of the International Society for Burn Injuries|November 24, 2001
Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in miceD Mikus, P Sikiric, S Seiwerth, et al.
Journal of Pharmacological Sciences|April 25, 2007
Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat and therapeutic potential of the gastric pentadecapeptide BPC 157Ivan Dobric, Petar Drvis, Igor Petrovic, et al.
World Journal of Gastroenterology|January 24, 2018
Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insightsAntonija Duzel, Josipa Vlainic, Marko Antunovic, et al.
Current Pharmaceutical Design|July 13, 2018
BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone HealingSven Seiwerth, Rudolf Rucman, Branko Turkovic, et al.
Journal of Physiology, Paris|October 12, 2001
Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidineI Prkacin, J Separovic, G Aralicia, et al.
Journal of Physiology, Paris|May 1, 1997
Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in ratsP Sikiric, S Seiwerth, Z Grabarevic, et al.
Digestive Diseases and Sciences|May 1, 1997
Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized rats: a model for cytoprotective studiesP Sikirić, D Mikus, S Seiwerth, et al.
Inflammopharmacology|July 9, 2024
New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. significance of counteraction of vascular and multiorgan failure of occlusion/occlusion-like syndrome in cytoprotection/organoprotectionPredrag Sikiric, Marko Sever, Ivan Krezic, et al.
Pageof 33

Showing results (271-280 of 321) with videos related to

Sort By:
Pageof 33
International Journal of Molecular Sciences|May 27, 2026
Early Peripheral Blood <i>WT1</i> Expression Predicts Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid LeukemiaViktor Blaslov, Margareta Radic Antolic, Ivana Horvat, et al.
Pharmaceuticals (Basel, Switzerland)|April 27, 2024
The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter ActivityPredrag Sikiric, Alenka Boban Blagaic, Sanja Strbe, et al.
Burns : Journal of the International Society for Burn Injuries|November 24, 2001
Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in miceD Mikus, P Sikiric, S Seiwerth, et al.
Journal of Pharmacological Sciences|April 25, 2007
Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat and therapeutic potential of the gastric pentadecapeptide BPC 157Ivan Dobric, Petar Drvis, Igor Petrovic, et al.
World Journal of Gastroenterology|January 24, 2018
Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insightsAntonija Duzel, Josipa Vlainic, Marko Antunovic, et al.
Current Pharmaceutical Design|July 13, 2018
BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone HealingSven Seiwerth, Rudolf Rucman, Branko Turkovic, et al.
Journal of Physiology, Paris|October 12, 2001
Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidineI Prkacin, J Separovic, G Aralicia, et al.
Journal of Physiology, Paris|May 1, 1997
Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in ratsP Sikiric, S Seiwerth, Z Grabarevic, et al.
Digestive Diseases and Sciences|May 1, 1997
Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized rats: a model for cytoprotective studiesP Sikirić, D Mikus, S Seiwerth, et al.
Inflammopharmacology|July 9, 2024
New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. significance of counteraction of vascular and multiorgan failure of occlusion/occlusion-like syndrome in cytoprotection/organoprotectionPredrag Sikiric, Marko Sever, Ivan Krezic, et al.
Pageof 33